Clinical Trial Update: APatinib Plus Chemotherapy vErsus Chemotherapy As First-line Treatment for Advanced NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial of Apatinib plus chemotherapy versus chemotherapy for first-line treatment of advanced non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Apatinib (apatinib)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Lung Cancer | Phase 2 | Status: WITHDRAWN